F. Penault Llorca

716 total citations
14 papers, 273 citations indexed

About

F. Penault Llorca is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, F. Penault Llorca has authored 14 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in F. Penault Llorca's work include HER2/EGFR in Cancer Research (5 papers), Breast Cancer Treatment Studies (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). F. Penault Llorca is often cited by papers focused on HER2/EGFR in Cancer Research (5 papers), Breast Cancer Treatment Studies (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). F. Penault Llorca collaborates with scholars based in France, United States and Belgium. F. Penault Llorca's co-authors include Éric Raymond, D. Azria, Jean‐Philippe Spano, Jean‐Christophe Théry, S. Giard, Monique Cohen, Jean‐Marc Classe, C. Tunon de Lara, Fréderic Fina and S Romain and has published in prestigious journals such as Annals of Oncology, European Journal of Cancer and Oncotarget.

In The Last Decade

F. Penault Llorca

13 papers receiving 267 citations

Peers

F. Penault Llorca

ONCOL

PFM

SURGE

Patrick Tas France

Hemangini H. Vora India

Carlo Fremd Germany

Nobuhiro Imanaka Japan

Angela Calabrese Italy

Seog Young Kim South Korea

Jingtong Zhai China

Johan Forssell Sweden

Ch. Gollan Germany

Giovanna Bosshard Switzerland

Patrick Tas France

F. Penault Llorca

91 ×0.6

ONCOL

129 ×1.1

137 ×2.0

PFM

66 ×1.0

82 ×1.5

SURGE

Citations per year, relative to F. Penault Llorca F. Penault Llorca (= 1×) peers Patrick Tas

Countries citing papers authored by F. Penault Llorca

Since Specialization

Citations

This map shows the geographic impact of F. Penault Llorca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Penault Llorca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Penault Llorca more than expected).

Fields of papers citing papers by F. Penault Llorca

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Penault Llorca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Penault Llorca. The network helps show where F. Penault Llorca may publish in the future.

Co-authorship network of co-authors of F. Penault Llorca

This figure shows the co-authorship network connecting the top 25 collaborators of F. Penault Llorca. A scholar is included among the top collaborators of F. Penault Llorca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Penault Llorca. F. Penault Llorca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Pujol, Pascal, Kévin Yauy, Amandine Coffy, et al.. (2022). Predominance of BRCA2 Mutation and Estrogen Receptor Positivity in Unselected Breast Cancer with BRCA1 or BRCA2 Mutation. Cancers. 14(13). 3266–3266. 5 indexed citations

Saji, Shigehira, EA Mittendorf, Nadia Harbeck, et al.. (2020). 3MO IMpassion031: Results from a phase III study of neoadjuvant (neoadj) atezolizumab + chemo in early triple-negative breast cancer (TNBC). Annals of Oncology. 31. S1243–S1243. 2 indexed citations

Daures, Marine, Marjolaine Ngollo, Mouhamed Idrissou, et al.. (2017). Soy Phytoestrogens on DNA Methylation in Prostate Cancer. SPIRE - Sciences Po Institutional REpository. 3(1). 1 indexed citations

Houvenaeghel, Gilles, Jean‐Marc Classe, Jean-Rémy Garbay, et al.. (2014). Prognostic value of isolated tumor cells and micrometastases of lymph nodes in early-stage breast cancer: A French sentinel node multicenter cohort study. The Breast. 23(5). 561–566. 30 indexed citations

Théry, Jean‐Christophe, Jean‐Philippe Spano, D. Azria, Éric Raymond, & F. Penault Llorca. (2014). Resistance to human epidermal growth factor receptor type 2-targeted therapies. European Journal of Cancer. 50(5). 892–901. 45 indexed citations

Chêne, G., Nina Radosevic‐Robin, Anne Cayre, et al.. (2014). Morphological and immunohistochemical study of ovarian and tubal dysplasia associated with tamoxifen. European Journal of Histochemistry. 58(2). 2251–2251. 8 indexed citations

Dupouy, Sandra, Zherui Wu, Najat Mourra, et al.. (2014). Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice. Oncotarget. 5(18). 8235–8251. 36 indexed citations

Dalenc, Florence, et al.. (2011). 5166 POSTER PT1a,bN0M0 Breast Carcinoma Characteristics and Management: the French ODISSEE Cohort. European Journal of Cancer. 47. S379–S380.

Raynaud, Christophe M., F. Penault Llorca, Paolo Nucíforo, et al.. (2010). DNA Damage Repair and Telomere Length in Normal Breast, Preneoplastic Lesions, and Invasive Cancer. American Journal of Clinical Oncology. 33(4). 341–345. 30 indexed citations

10.

Houvenæghel, Gilles, Claude Nos, S. Giard, et al.. (2008). A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis. European Journal of Surgical Oncology. 35(7). 690–695. 62 indexed citations

11.

Crouet, H., Gilles Houvenaeghel, Agnès Leroux, et al.. (2008). Intra-operative sentinel lymph node metastasis detection in breast cancer by “One-step Nucleic Acid Amplification (OSNA)” – results of the French multicentre prospective study. European Journal of Cancer Supplements. 6(7). 54–54. 1 indexed citations

12.

Lamy, Pierre‐Jean, Isabelle Nanni, Fréderic Fina, et al.. (2006). Reliability and Discriminant Validity of HER2 Gene Quantification and Chromosome 17 Aneusomy Analysis by Real-Time PCR in Primary Breast Cancer. The International Journal of Biological Markers. 21(1). 20–29. 17 indexed citations

13.

Lamy, Pierre‐Jean, Isabelle Nanni, Fréderic Fina, et al.. (2006). Reliability and discriminant validity of HER2 gene quantification and chromosome 17 aneusomy analysis by real-time PCR in primary breast cancer. The International Journal of Biological Markers. 21(1). 20–29. 24 indexed citations

14.

Llorca, F. Penault, Xavier Sastre, Maryse Fiche, et al.. (1999). Pathological response to neoadjuvant chemotherapy Final results of a prospective randomized trial of 4AT vs 4AC as induction therapy in patients with operable breast cancer using Sataloff classification. Breast Cancer Research and Treatment. 57(1). 67. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact